Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Difference in Incontinence Prevalence Between High Impact Athletes, Low Impact Athletes and Sedentary Subjects

21 juillet 2026 mis à jour par: Noemi Moreno-Segura, University of Valencia

Difference in Incontinence Prevalence Between High Impact Athletes, Low Impact Athletes and Sedentary Subjects. A Functional Analysis

This observational cross-sectional study aims to investigate the association between participation in high-impact sports, physical activity level, and urinary incontinence in young adults. The study will compare six groups based on sex and physical activity level: male and female high-impact sports participants, physically active males and females who do not participate in high-impact sports, and sedentary males and females.

Participants aged 18-35 years will undergo a single assessment including sociodemographic and medical information, physical activity assessment, urinary incontinence questionnaires, sport-related characteristics, psychosocial questions regarding the influence of social taboos on questionnaire responses, lower-limb muscle strength testing using a load cell, and vertical jump performance assessment.

The study aims to describe the prevalence, severity, type, and impact of urinary incontinence across different activity levels and sexes, and to explore potential associations with lower-limb strength, jump performance, and sport-related characteristics.

Aperçu de l'étude

Statut

Inscription sur invitation

Description détaillée

Urinary incontinence is a common condition that may affect both women and men and has been associated with physical activity and participation in high-impact sports. Although regular exercise provides substantial health benefits, repetitive increases in intra-abdominal pressure during high-impact activities may contribute to pelvic floor dysfunction in susceptible individuals. Most previous studies have focused on female athletes from specific sports, while evidence including both sexes and different physical activity levels remains limited.

This observational cross-sectional study will compare urinary incontinence characteristics among six population groups defined according to sex and physical activity level: male and female participants in high-impact sports, physically active males and females who do not participate in high-impact sports, and sedentary males and females.

Participants will attend a single face-to-face assessment session after providing written informed consent. During the visit, sociodemographic and clinical information, physical activity characteristics, sport-related variables, urinary incontinence questionnaires, and psychosocial questions related to social taboos and response honesty will be collected. Lower-limb muscle strength will be assessed using a load cell system, and jump performance will be evaluated using the My Jump 2 application.

The primary objective is to compare the prevalence, severity, type, and impact of urinary incontinence across the different study groups. Secondary analyses will explore the relationship between urinary incontinence and physical activity level, lower-limb muscle strength, jump performance, sport-related characteristics, and selected demographic and clinical variables.

Participants will be recruited through social media, institutional dissemination, and sports clubs using voluntary convenience and snowball sampling. All assessments will be performed by trained researchers following standardized procedures.

Type d'étude

Observationnel

Inscription (Estimé)

270

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Valencia
      • Valencia, Valencia, Espagne, 46010
        • Gascó Oliag, 5

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte

Accepte les volontaires sains

Oui

Méthode d'échantillonnage

Échantillon de probabilité

Population étudiée

The study population will consist of community-dwelling adults aged 18-35 years recruited from the general population and sports clubs. Participants will include males and females who regularly participate in high-impact sports, physically active individuals who do not participate in high-impact sports, and sedentary individuals. Recruitment will be conducted through social media, institutional advertisements, sports clubs, and snowball sampling. All participants will voluntarily contact the research team and will undergo a single face-to-face assessment after providing written informed consent.

La description

Inclusion Criteria:

  • Adults aged 18 to 35 years.
  • Male or female participants.
  • Able to understand and provide written informed consent.
  • Belong to one of the following groups:

Regular participation in high-impact sports (≥2 training sessions per week for at least the previous 2 years).

Physically active individuals meeting the World Health Organization recommendations (≥150 minutes/week of moderate-intensity activity, ≥75 minutes/week of vigorous-intensity activity, or an equivalent combination), without regular participation in high-impact sports.

Sedentary individuals who do not meet the World Health Organization physical activity recommendations.

Exclusion Criteria:

  • Pregnancy or childbirth within the previous 12 months.
  • Current or recent urinary tract infection.
  • History of urogynecological disease or pelvic/urogynecological surgery.
  • Body mass index (BMI) >35 kg/m².
  • Inability to understand or complete the study procedures or questionnaires in Spanish or English.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

Cohortes et interventions

Groupe / Cohorte
Intervention / Traitement
Male High-Impact Sports Participants
Males aged 18-35 years who regularly participate in high-impact sports (at least twice per week for the previous two years).
No intervention
Female High-Impact Sports Participants
Females aged 18-35 years who regularly participate in high-impact sports (at least twice per week for the previous two years).
No intervention
Physically Active Males
Males aged 18-35 years who meet the World Health Organization physical activity recommendations but do not participate in high-impact sports.
No intervention
Physically Active Females
Females aged 18-35 years who meet the World Health Organization physical activity recommendations but do not participate in high-impact sports.
No intervention
Sedentary Males
Males aged 18-35 years who do not meet the World Health Organization physical activity recommendations.
No intervention
Sedentary Females
Females aged 18-35 years who do not meet the World Health Organization physical activity recommendations.
No intervention

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Urinary incontinence severity
Délai: Baseline (single study visit)
Urinary incontinence severity assessed using the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF). Higher scores indicate greater symptom severity and impact on quality of life. The total score ranges from 0 to 21, with higher scores indicating more severe urinary incontinence symptoms and greater impact on quality of life.
Baseline (single study visit)

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Urinary incontinence-related quality of life
Délai: Baseline (single study visit)
Quality of life associated with urinary incontinence assessed using the Incontinence Quality of Life Questionnaire (I-QOL). The total score ranges from 0 to 100, with higher scores indicating better urinary incontinence-related quality of life.
Baseline (single study visit)
Lower-limb muscle strength
Délai: Baseline (single study visit)
Maximum voluntary force and mean voluntary force of hip adduction, abduction, flexion, extension, internal rotation, and external rotation measured using a load cell and ChronoJump software.
Baseline (single study visit)
Vertical jump performance
Délai: Baseline (single study visit)
Vertical jump performance assessed using the My Jump 2 application.
Baseline (single study visit)
Physical activity level
Délai: Baseline (single study visit)
Physical activity level assessed using the International Physical Activity Questionnaire (IPAQ). Physical activity is expressed as metabolic equivalent (MET)-minutes per week and classified into low, moderate, or high physical activity levels, according to the IPAQ scoring protocol. Higher MET-minutes per week indicate greater levels of physical activity.
Baseline (single study visit)

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

24 septembre 2025

Achèvement primaire (Estimé)

31 décembre 2026

Achèvement de l'étude (Estimé)

31 décembre 2026

Dates d'inscription aux études

Première soumission

2 juillet 2026

Première soumission répondant aux critères de contrôle qualité

13 juillet 2026

Première publication (Réel)

17 juillet 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

23 juillet 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

21 juillet 2026

Dernière vérification

1 juillet 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner